Jeff Ubben (Trades, Portfolio), founder, chief executive officer and chief investment officer of ValueAct Holding LP, made multiple buys and sells of stocks in just four companies in the fourth quarter. That isn’t typical. Normally, he buys and sells stocks in many companies in a quarter but usually once, rarely on multiple occasions.
He added to his stakes in Valeant Pharmaceuticals International Inc (VRX, Financial) and Allison Transmission Holdings Inc (ALSN, Financial). He reduced his stakes in Adobe Systems Inc (ADBE, Financial) and CBRE Group Inc (CBG, Financial).
Valeant Pharmaceuticals is a Montreal-based pharmaceutical company. Ubben purchased Valeant stock on Nov. 24 for an average price of $142.56 per share that had a 0.2% impact on his portfolio, then he made another purchase on Dec. 10 for an average price of $137.96 per share that had a 0.23% impact on his portfolio.
Allison Transmission is an Indiana-based manufacturer of commercial automatic transmissions and hybrid propulsion systems. Ubben purchased Allison stock four times in two weeks in the fourth quarter – on Oct. 3 for an average price of $28.13 per share; on Oct. 9 for an average price of $28.22 per share; on Oct. 13 for an average price of $26.55 per share, and on Oct. 15 for an average price of $27.33 per share. The first purchase had a 0.12% impact on his portfolio. The second had a 0.06% impact, the third had a 0.04% impact, and the fourth had a 0.02% impact.
He sold portions of his holdings in Adobe Systems, a California-based computer software company, on three occasions within one week in December, and he sold portions of his stake in CBRE Group, a Los Angeles-based commercial real estate company, on two occasions within three days in November.
Ubben sold stock in Adobe Systems on Dec. 17, on Dec. 22 and on Dec. 24, each time for an average price of $72.28 per share. The first sale had a -1.03% impact on his portfolio. The second had a -2.54% impact on the portfolio, and the third had -0.35% impact.
He sold portions of his holdings in CBRE Group on Nov. 3 and Nov. 6. The first sale had a -0.06% impact on his portfolio; those shares were sold for an average price of $31.47 per share. The second sale had a -0.12% impact on his portfolio; on that occasion, the stock sold for an average price of $32.08 per share.
View the latest stock picks from Jeff Ubben (Trades, Portfolio) here. Not a Premium Member of GuruFocus? Try it free for 7 days.
